Wilson D R, Siebers A, Finlay B B
Department of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada.
Infect Immun. 1998 Oct;66(10):4884-94. doi: 10.1128/IAI.66.10.4884-4894.1998.
Although substantial advancements have been made in the development of efficacious acellular vaccines against Bordetella pertussis, continued progress requires better understanding of the antigenic makeup of B. pertussis virulence factors, including filamentous hemagglutinin (FHA). To identify antigenic regions of FHA, phage display libraries constructed by using random fragments of the 10-kbp EcoRI fragment of B. pertussis fhaB were affinity selected with rabbit anti-FHA polyclonal antibodies. Characterization of antibody-reactive clones displaying FHA-derived peptides identified 14 antigenic regions, each containing one or more epitopes. A number of clones mapped within regions containing known or putative FHA adhesin domains and may be relevant for the generation of protective antibodies. The immunogenic potential of the phage-displayed peptides was assessed indirectly by comparing their recognition by antibodies elicited by sodium dodecyl sulfate (SDS)-denatured and native FHA and by measuring the inhibition of this recognition by purified FHA. FHA residues 1929 to 2019 may contain the most dominant linear epitope of FHA. Clones mapping to this region accounted for ca. 20% of clones recovered from the initial library selection and screening procedures. They are strongly recognized by sera against both SDS-denatured and native FHA, and this recognition is readily inhibited by purified FHA. Given also that this region includes a factor X homolog (J. Sandros and E. Tuomanen, Trends Microbiol. 1:192-196, 1993) and that the single FHA epitope (residues 2001 to 2015) was unequivocally defined in a comparable study by E. Leininger et al. (J. Infect. Dis. 175:1423-1431, 1997), peptides derived from residues of 1929 to 2019 of FHA are strong candidates for future protection studies.
尽管在开发有效的抗百日咳博德特氏菌无细胞疫苗方面已取得了重大进展,但要取得持续进展,需要更好地了解百日咳博德特氏菌毒力因子的抗原组成,包括丝状血凝素(FHA)。为了鉴定FHA的抗原区域,用百日咳博德特氏菌fhaB的10-kbp EcoRI片段的随机片段构建的噬菌体展示文库用兔抗FHA多克隆抗体进行亲和选择。对展示FHA衍生肽的抗体反应性克隆的表征鉴定出14个抗原区域,每个区域包含一个或多个表位。许多克隆定位在包含已知或推定的FHA粘附素结构域的区域内,可能与保护性抗体的产生有关。通过比较噬菌体展示肽被十二烷基硫酸钠(SDS)变性和天然FHA引发的抗体的识别情况,并通过测量纯化的FHA对这种识别的抑制作用,间接评估了噬菌体展示肽的免疫原性潜力。FHA的1929至2019位残基可能包含FHA最主要的线性表位。定位到该区域的克隆约占从初始文库选择和筛选程序中回收的克隆的20%。它们被抗SDS变性和天然FHA的血清强烈识别,并且这种识别很容易被纯化的FHA抑制。此外,鉴于该区域包括一个X因子同源物(J. Sandros和E. Tuomanen,《微生物学趋势》1:192 - 196,1993),并且E. Leininger等人在一项类似研究中明确界定了单个FHA表位(2001至2015位残基)(《传染病杂志》175:1423 - 1431,1997),来自FHA的1929至2019位残基的肽是未来保护性研究的有力候选物。